A Study to Assess Pharmacokinetic, Pharmacodynamic, Safety and Tolerability of ASKP1240 in de novo Kidney Transplantation

Trial Identifier: 7163-CL-0103
Sponsor: Astellas Pharma Inc.
Collaborator:
Kyowa Hakko Kirin Company, Limited
Start Date: November 2010
Primary Completion Date: January 2012
Study Completion Date: January 2012
Condition: Kidney Transplants

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
United States, CA Palo Alto, CA, United States, 94304
United States, CA San Diego, CA, United States, 92123
United States, CA San Francisco, CA, United States, 94115
United States, CA San Francisco, CA, United States, 94143
United States, CO Aurora, CO, United States, 80045
United States, IL Chicago, IL, United States, 60612
United States, MI Ann Arbor, MI, United States, 48109
United States, NJ Livingston, NJ, United States, 07039
United States, NY Valhalla, NY, United States, 10595
United States, Ohio Cincinnati, Ohio, United States, 45219
United States, PA Harrisburg, PA, United States, 17104
United States, TN Memphis, TN, United States, 38104
United States, TX Dallas, TX, United States, 75246
United States, TX Houston, TX, United States, 77030
United States, UT Salt Lake City, UT, United States, 84132
United States, WI Madison, WI, United States, 53705
USA, GA Atlanta, GA, USA, 30322
USA, IL Maywood, IL, USA, 60153
USA, MA Boston, MA, USA, 02215
USA, NC Chapel Hill, NC, USA, 27599
USA, North Carolina Durham, North Carolina, USA, 27710